Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Company Logo The Cancer Molecular Diagnostics market is seeing accelerated growth driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. Key opportunities lie in companion ...

October 27, 2025- ( Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Co-Diagnostics (Nasdaq: CODX) entered a joint venture with Arabian Eagle Manufacturing to develop and commercialize Co-Dx ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...

Japan-headquartered Atonarp has raised $50 million from a Series D funding round led by Silicon Valley-based investor WRVI Capital and supported by Furukawa Electric, Japan Post Investment, Boscolo ...

An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...

The Jongkuntang Gochon Foundation announced that it has awarded the 18th Gochon Award to Molbio Diagnostics, a molecular ...

Roche’s diagnostics business continues to be buffeted by China headwinds, but the Swiss major believes it has enough ...